Gene therapy in the putamen for curing AADC deficiency and Parkinson's disease

This commentary provides an overview of the putamen as an established target site for gene therapy in treating aromatic l‐amino acid decarboxylase (AADC) deficiency and Parkinson’s disease, two debilitating neurological disorders that involve motor dysfunction caused by dopamine deficiencies. The ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwu, Paul Wuh‐Liang, Kiening, Karl, Anselm, Irina, Compton, David R, Nakajima, Takeshi, Opladen, Thomas, Pearl, Phillip L, Roubertie, Agathe, Roujeau, Thomas, Muramatsu, Shin‐ichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422070/
https://www.ncbi.nlm.nih.gov/pubmed/34423905
http://dx.doi.org/10.15252/emmm.202114712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422070/
https://www.ncbi.nlm.nih.gov/pubmed/34423905
http://dx.doi.org/10.15252/emmm.202114712

Ejemplares similares